Rocket Pharmaceuticals Inc. (RCKT) Statistics & Valuation Metrics - Stocknear

Rocket Pharmaceuticals In...

NASDAQ: RCKT · Real-Time Price · USD
3.26
0.07 (2.19%)
At close: Sep 26, 2025, 3:59 PM
3.25
-0.44%
After-hours: Sep 26, 2025, 06:08 PM EDT

Rocket Pharmaceuticals Statistics

Share Statistics

Rocket Pharmaceuticals has 107.9M shares outstanding. The number of shares has increased by 18.42% in one year.

107.9M
18.42%
1.04%
97.73%
98.68M
2,948
0.08%

Short Selling Information

The latest short interest is 14.89M, so 13.8% of the outstanding shares have been sold short.

14.89M
13.8%
26.87%
8.76

Valuation Ratios

The PE ratio is -4.61 and the forward PE ratio is -2.64. Rocket Pharmaceuticals's PEG ratio is 0.71.

-4.61
-2.64
0
9.5
2.57
-5.53
0.71
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Rocket Pharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 9.3, with a Debt / Equity ratio of 0.06.

9.3
9.3
0.06
-0.1
-0.12
-144.86

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-865.37K
299
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -82.34% in the last 52 weeks. The beta is 0.62, so Rocket Pharmaceuticals's price volatility has been higher than the market average.

0.62
-82.34%
3.19
6.49
51.78
3,835,861

Income Statement

n/a
-9.38M
-273.2M
-258.75M
-247.49M
-256.86M
-2.73
Full Income Statement

Balance Sheet

The company has 163.63M in cash and 25.5M in debt, giving a net cash position of 138.14M.

163.63M
25.5M
138.14M
-1.22B
420.98M
233.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -209.72M and capital expenditures -5.86M, giving a free cash flow of -215.59M.

-209.72M
-5.86M
-215.59M
-2.27
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

RCKT does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for RCKT is $9, which is 176.1% higher than the current price. The consensus rating is "Buy".

$9
176.1%
Buy
13
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jan 5, 2018. It was a backward split with a ratio of 1:4.

Jan 5, 2018
backward
1:4

Scores

-2.66
1